MDPI and ACS Style
Santra, S.; Sharapov, A.D.; Fatykhov, R.F.; Potapova, A.P.; Khalymbadzha, I.A.; Valieva, M.I.; Kopchuk, D.S.; Zyryanov, G.V.; Bunev, A.S.; Melekhin, V.V.;
et al. Xanthone-1,2,4-triazine and Acridone-1,2,4-triazine Conjugates: Synthesis and Anticancer Activity. Pharmaceuticals 2023, 16, 403.
https://doi.org/10.3390/ph16030403
AMA Style
Santra S, Sharapov AD, Fatykhov RF, Potapova AP, Khalymbadzha IA, Valieva MI, Kopchuk DS, Zyryanov GV, Bunev AS, Melekhin VV,
et al. Xanthone-1,2,4-triazine and Acridone-1,2,4-triazine Conjugates: Synthesis and Anticancer Activity. Pharmaceuticals. 2023; 16(3):403.
https://doi.org/10.3390/ph16030403
Chicago/Turabian Style
Santra, Sougata, Ainur D. Sharapov, Ramil F. Fatykhov, Anastasya P. Potapova, Igor A. Khalymbadzha, Maria I. Valieva, Dmitry S. Kopchuk, Grigory V. Zyryanov, Alexander S. Bunev, Vsevolod V. Melekhin,
and et al. 2023. "Xanthone-1,2,4-triazine and Acridone-1,2,4-triazine Conjugates: Synthesis and Anticancer Activity" Pharmaceuticals 16, no. 3: 403.
https://doi.org/10.3390/ph16030403